Daikaffil Chemicals India Ltd (DAIKAFFI) — shareholding pattern, promoter holding, financials and share price
About Daikaffil Chemicals India Ltd (DAIKAFFI)
Daikaffil Chemicals India Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as DAIKAFFI and on the BSE under scrip code 530825. Its ISIN is INE789B01018.
Incorporated in 1992, Daikaffil Chemicals India Ltd manufactures and trades Organic Dyes and Intermediaries [1]
Daikaffil Chemicals India Ltd. is a chemical manufacturing company established in June 1992, specializing in organic chemicals and intermediaries, including Optical Brightening Agents (OBAs).
The company collaborates with Japanese technology, resulting in lower input costs and enhanced automation instead of manual labor processes.
Listed peers in Specialty Chemicals: Seya Industries Ltd, Dynamic Industries Ltd, Machhar Industries Ltd, Vikram Aroma Ltd, Chemiesynth (Vapi) Ltd, Organic Coatings Ltd.
Valuation & Returns
10 Jul 2026At ₹47.27 a share on 10 Jul 2026, Daikaffil Chemicals India Ltd (DAIKAFFI) was valued at a price-to-earnings ratio of 78.07x against an industry P/E of 45.11x and a price-to-book of 1.11x on a book value of ₹42.56 per share as of Mar 2018. Solomo computes return on equity of 1.42% and return on capital employed of 2.71% from filed results. Earnings ratios use consolidated results for the twelve months Dec 2017 to Mar 2026.
- P/E
- 78.07x
- Industry P/E
- 45.11x
- P/B
- 1.11x
- EPS (TTM)
- ₹0.61
- Book value / share
- ₹42.56
- ROE
- 1.42%
- ROCE
- 2.71%
- ROA
- 1.19%
- Debt / equity
- 0x
- Dividend yield
- 2.51%
- EBITDA margin
- 9.32%
- 52-week range
- ₹28.48 – ₹169.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Daikaffil Chemicals India Ltd (DAIKAFFI) reported revenue of ₹13.35 crore, net profit of ₹-2.21 crore and earnings per share of ₹-3.68. That compares with revenue of ₹22.82 crore and net profit of ₹2.37 crore in Mar 2018. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹1.97 crore and net profit ₹-0.93 crore (consolidated).
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 34.43 | 27.41 | 26.44 | 22.82 | 13.35 |
| Net profit (₹ cr) | 1.54 | 2.11 | 2.45 | 2.37 | -2.21 |
| EPS (₹) | 2.58 | 3.5 | 4.07 | 3.98 | -3.68 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -14.12% | -13.76% | -2.77% | -13.69% |
| Profit growth | - | - | - | -3.27% |
| Stock price CAGR | 2% | 3% | 25% | -69% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 53.79% of Daikaffil Chemicals India Ltd (DAIKAFFI) (up 1.14 pp QoQ), foreign institutional investors (FII) hold 0% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹28 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Mahendra Girdharilal 4.5%, Investor Education And Protection Fund Authority Ministry Of Corporate Affairs 3.04%, Sandeep Kapadia 2.5%, HUF 2.13%, Lincoln P Coelho 1.67%, Pharma Synth Formulations Limited 1.5%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 53.79% | - | 0% | 0% | 46.21% |
| Mar 2026 | 52.65% | - | 0% | 0% | 47.35% |
| Dec 2025 | 52.65% | - | - | - | 47.35% |
| Sep 2025 | 52.65% | - | - | - | 47.35% |
| Jun 2025 | 52.65% | - | - | - | 47.35% |
| Mar 2025 | 52.65% | - | - | - | 47.35% |
| Dec 2024 | 51.25% | - | - | - | 48.75% |
| Sep 2024 | 49.43% | - | - | - | 50.57% |